Temperature‐Sensitive Nanocapsules for Controlled Drug Release Caused by Magnetically Triggered Structural Disruption

Abstract

AbstractSelf‐assembled nanocapsules containing a hydrophilic core and a crosslinked yet thermosensitive shell are successfully prepared using poly(ethylene‐oxide)‐poly(propylene‐oxide)‐poly(ethylene‐oxide) block copolymers, 4‐nitrophenyl chloroformate, gelatin, and 1‐ethyl‐3‐(3‐dimethylaminopropyl) carbodiimide. The core is further rendered magnetic by incorporating iron oxide nanoparticles via internal precipitation to enable externally controlled actuation under magnetic induction. The spherical nanocapsules exhibit a hydrophilic‐to‐hydrophobic transition at a characteristic but tunable temperature reaching 40 °C, triggering a size contraction and shrinkage of the core. The core content experiences very little leakage at 25 °C, has a half life about 5 h at 45 °C, but bursts out within a few minutes under magnetic heating due to iron oxide coarsening and core/shell disruption. Such burst‐like response may be utilized for controlled drug release as illustrated here using a model drug Vitamin B12.